The latest from FAKnostics

Introducing FAKnostic platform

Our FAK inhibitor for the treatment of melanoma is now in preclinical testing

FAKnostics at AACR Annual Meeting

1

We are developing next generation drugs that inhibit tumor growth through targeting protein-protein interactions on the FAK scaffold.

FAKnostics LLC
Phoenix Biomedical Campus
475 N. 5th St., Rm E 530 Bay A
Phoenix, AZ 85004

bottom of page